Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 14, 2024CancersOpen Access

Retrospective Long-Term Evaluation of Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma over 20 Years

View Full Paper
Ask AI
Bookmark
Share

Authors

TVThomas J. VoglHAHamzah AdwanLWL Wolff

Discussion

Loading...

Member takes

Overview

Retrospective study demonstrates extended overall survival following chemoembolization in hepatocellular carcinoma, highlighting the prognostic impact of liver function and portal vein thrombosis.

Key Points

  • Conventional transarterial chemoembolization prolongs overall survival in hepatocellular carcinoma, offering the largest extension under neoadjuvant intention.
  • Median overall survival reached 700 days, while portal vein thrombosis significantly reduced survival with a hazard ratio of 2.19 in treated individuals.
  • Retrospective evaluation using Kaplan-Meier estimator and MRI confirms therapy benefits, but advanced Child-Pugh class highlights critical selection limits.

Cite This Study

Vogl et al. (2024) studied this question.

synapsesocial.com/papers/68e6f3b2b6db64358766e8ddhttps://doi.org/10.3390/cancers16081498
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Long-term Outcomes of Transcatheter Arterial Chemoembolization Combined With Radiofrequency Ablation as an Initial Treatment for Early-Stage Hepatocellular Carcinoma2021 · 70 citations
  2. 2Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization for the Treatment of Single Hepatocellular Carcinoma of 2 to 5 cm in Diameter: Comparison with Surgical Resection2013 · 61 citations
  3. 3Risk factors for hepatocellular carcinoma2012 · 76 citations
  4. 4Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis2017 · 742 citations
  5. 5Standardization of conventional chemoembolization for hepatocellular carcinoma2020 · 37 citations